GlaxoSmithKline PLC Revenue vs. Net Income

GSK Stock  USD 42.87  0.12  0.28%   
Based on the measurements of profitability obtained from GlaxoSmithKline PLC's financial statements, GlaxoSmithKline PLC ADR is performing exceptionally good at this time. It has a great probability to showcase excellent profitability results in April. Profitability indicators assess GlaxoSmithKline PLC's ability to earn profits and add value for shareholders. Days Of Sales Outstanding is expected to rise to 95.02 this year, although the value of Price To Sales Ratio will most likely fall to 3.14. At this time, GlaxoSmithKline PLC's Accumulated Other Comprehensive Income is quite stable compared to the past year. Income Tax Expense is expected to rise to about 1.2 B this year, although the value of Total Other Income Expense Net is projected to rise to (877.8 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.780.7007
Moderately Up
Pretty Stable
Net Profit Margin0.220.1625
Significantly Up
Pretty Stable
Operating Profit Margin0.320.2306
Significantly Up
Slightly volatile
Pretax Profit Margin0.310.2001
Way Up
Slightly volatile
Return On Assets0.150.0835
Way Up
Slightly volatile
For GlaxoSmithKline PLC profitability analysis, we use financial ratios and fundamental drivers that measure the ability of GlaxoSmithKline PLC to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well GlaxoSmithKline PLC ADR utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between GlaxoSmithKline PLC's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of GlaxoSmithKline PLC ADR over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Is GlaxoSmithKline PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlaxoSmithKline PLC. If investors know GlaxoSmithKline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlaxoSmithKline PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.77)
Dividend Share
0.58
Earnings Share
3.02
Revenue Per Share
14.97
Quarterly Revenue Growth
0.092
The market value of GlaxoSmithKline PLC ADR is measured differently than its book value, which is the value of GlaxoSmithKline that is recorded on the company's balance sheet. Investors also form their own opinion of GlaxoSmithKline PLC's value that differs from its market value or its book value, called intrinsic value, which is GlaxoSmithKline PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlaxoSmithKline PLC's market value can be influenced by many factors that don't directly affect GlaxoSmithKline PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlaxoSmithKline PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlaxoSmithKline PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlaxoSmithKline PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

GlaxoSmithKline PLC ADR Net Income vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining GlaxoSmithKline PLC's current stock value. Our valuation model uses many indicators to compare GlaxoSmithKline PLC value to that of its competitors to determine the firm's financial worth.
GlaxoSmithKline PLC ADR is rated as one of the top companies in revenue category among related companies. It is one of the top stocks in net income category among related companies making up about  0.16  of Net Income per Revenue. The ratio of Revenue to Net Income for GlaxoSmithKline PLC ADR is roughly  6.15 . At this time, GlaxoSmithKline PLC's Net Income is quite stable compared to the past year.. Comparative valuation analysis is a catch-all model that can be used if you cannot value GlaxoSmithKline PLC by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for GlaxoSmithKline PLC's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GlaxoSmithKline PLC's earnings, one of the primary drivers of an investment's value.

GlaxoSmithKline Revenue vs. Competition

GlaxoSmithKline PLC ADR is rated as one of the top companies in revenue category among related companies. Market size based on revenue of Health Care industry is currently estimated at about 37.63 Billion. GlaxoSmithKline PLC totals roughly 30.33 Billion in revenue claiming about 81% of equities under Health Care industry.

GlaxoSmithKline Net Income vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

GlaxoSmithKline PLC

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
30.33 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

GlaxoSmithKline PLC

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
4.93 B
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

GlaxoSmithKline Net Income Comparison

GlaxoSmithKline PLC is currently under evaluation in net income category among related companies.

GlaxoSmithKline PLC Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in GlaxoSmithKline PLC, profitability is also one of the essential criteria for including it into their portfolios because, without profit, GlaxoSmithKline PLC will eventually generate negative long term returns. The profitability progress is the general direction of GlaxoSmithKline PLC's change in net profit over the period of time. It can combine multiple indicators of GlaxoSmithKline PLC, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2024
Accumulated Other Comprehensive Income1.6 B1.7 B
Operating IncomeBB
Income Before Tax6.1 B4.8 B
Total Other Income Expense Net-924 M-877.8 M
Net Income4.9 B4.6 B
Income Tax Expense756 M1.2 B
Net Income Applicable To Common Shares13.5 B14.1 B
Net Income From Continuing Ops6.5 B9.4 B
Interest Income48 M45.6 M
Non Operating Income Net Other 0.00  0.00 
Net Interest Income-735 M-771.8 M
Change To Netincome-9.6 B-10.1 B
Net Income Per E B T 0.81  0.56 

GlaxoSmithKline Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on GlaxoSmithKline PLC. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of GlaxoSmithKline PLC position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the GlaxoSmithKline PLC's important profitability drivers and their relationship over time.

Use GlaxoSmithKline PLC in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if GlaxoSmithKline PLC position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlaxoSmithKline PLC will appreciate offsetting losses from the drop in the long position's value.

GlaxoSmithKline PLC Pair Trading

GlaxoSmithKline PLC ADR Pair Trading Analysis

The ability to find closely correlated positions to GlaxoSmithKline PLC could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace GlaxoSmithKline PLC when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back GlaxoSmithKline PLC - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling GlaxoSmithKline PLC ADR to buy it.
The correlation of GlaxoSmithKline PLC is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as GlaxoSmithKline PLC moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if GlaxoSmithKline PLC ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for GlaxoSmithKline PLC can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your GlaxoSmithKline PLC position

In addition to having GlaxoSmithKline PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Obamacare Thematic Idea Now

Obamacare
Obamacare Theme
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
View All  Next Launch
When determining whether GlaxoSmithKline PLC ADR is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlaxoSmithKline Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glaxosmithkline Plc Adr Stock. Highlighted below are key reports to facilitate an investment decision about Glaxosmithkline Plc Adr Stock:
Check out Risk vs Return Analysis.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for GlaxoSmithKline Stock analysis

When running GlaxoSmithKline PLC's price analysis, check to measure GlaxoSmithKline PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GlaxoSmithKline PLC is operating at the current time. Most of GlaxoSmithKline PLC's value examination focuses on studying past and present price action to predict the probability of GlaxoSmithKline PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GlaxoSmithKline PLC's price. Additionally, you may evaluate how the addition of GlaxoSmithKline PLC to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
To fully project GlaxoSmithKline PLC's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of GlaxoSmithKline PLC ADR at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include GlaxoSmithKline PLC's income statement, its balance sheet, and the statement of cash flows.
Potential GlaxoSmithKline PLC investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although GlaxoSmithKline PLC investors may work on each financial statement separately, they are all related. The changes in GlaxoSmithKline PLC's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on GlaxoSmithKline PLC's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.